Used in the treatment of short bowel syndrome, apraglutide works by enhancing intestinal absorption and promoting the growth of the intestinal lining. This helps patients reduce dependence on parenteral nutrition, improving quality of life. It is administered via injection and designed for long-acting effect, allowing less frequent dosing compared to other therapies. Its application is particularly beneficial for adults with stable conditions following intestinal adaptation.